Results 171 to 180 of about 1,051,148 (367)
Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab
Molecular Oncology, EarlyView.In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman +17 morewiley +1 more sourceGene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals
Nature Genetics, 2018 James J. Lee, R. Wedow, A. Okbay, Edward Kong, Omeed Maghzian, Meghan Zacher, Tuan Anh Nguyen-Viet, Peter Bowers, J. Sidorenko, R. Karlsson Linnér, M. Fontana, Tushar Kundu, Chanwook Lee, Hui Li, Ruoxi Li, Rebecca Royer, P. Timshel, R. Walters, E. Willoughby, L. Yengo, Michelle Babak Adam Robert K. Katarzyna Sarah L. Pierre Dav Agee Alipanahi Auton Bell Bryc Elson Fontanillas H, M. Agee, B. Alipanahi, A. Auton, R. Bell, K. Bryc, S. Elson, P. Fontanillas, D. Hinds, J. McCreight, K. Huber, N. Litterman, M. Mcintyre, Joanna L. Mountain, E. Noblin, C. Northover, S. Pitts, J. Sathirapongsasuti, O. V. Sazonova, J. Shelton, S. Shringarpure, C. Tian, V. Vacic, C. H. Wilson, Aysu Jonathan P. Mark Alan James J. Tune H. Cornelius A Okbay Beauchamp Fontana Lee Pers Rietveld Turley C, A. Okbay, J. Beauchamp, James J. Lee, T. Pers, C. A. Rietveld, P. Turley, Guo-Bo Chen, V. Emilsson, S. Meddens, Sven Oskarsson, Joseph K. Pickrell, Kevin Thom, P. Timshel, R. Vlaming, A. Abdellaoui, T. Ahluwalia, J. Bacelis, C. Baumbach, G. Bjornsdottir, J. Brandsma, M. P. Concas, J. Derringer, N. Furlotte, T. Galesloot, G. Girotto, Richa Gupta, Leanne M. Hall, Sarah E. Harris, E. Hofer, M. Horikoshi, J. Huffman, Kadri Kaasik, I. Kalafati, R. Karlsson, Augustine Kong, J. Lahti, S. J. van der Lee, C. D. Leeuw, P. Lind, Karl-Oskar Lindgren, Tian Liu, M. Mangino, J. Marten, E. Mihailov, Michael B. Miller, Peter J. van der Most, C. Oldmeadow, A. Payton, N. Pervjakova, W. Peyrot, Yong Qian, O. Raitakari, R. Rueedi, E. Salvi, Börge Schmidt, Katharina E. Schraut, Jianxin Shi, A. Smith, R. Poot, Beate St Pourcain, A. Teumer, G. Thorleifsson, N. Verweij, D. Vuckovic, J. Wellmann, H. Westra, Jingyun Yang, Wei Zhao, Zhihong Zhu, B. Alizadeh, N. Amin, A. Bakshi, S. Baumeister, G. Biino, K. Bønnelykke, P. Boyle, H. Campbell, Francesco P. Cappuccio, G. Davies, J. De Neve, P. Deloukas, I. Demuth, Jun Ding, P. Eibich, L. Eisele, N. Eklund, David M. Evans, J. Faul, M. Feitosa, A. Forstner, I. Gandin, Bjarni Gunnarsson, B. Halldórsson, T. Harris, Andrew C. Heath, L. Hocking, Elizabeth G. Holliday, G. Homuth, Michael A. Horan, J. Hottenga, P. D. de Jager, Peter K. Joshi, A. Jugessur, M. Kaakinen, M. Kähönen, S. Kanoni, Liisa Keltigangas-Järvinen, L. Kiemeney, I. Kolčić, S. Koskinen, A. Kraja, Martin Kroh, Z. Kutalik, A. Latvala, L. Launer, Maël P. Lebreton, D. Levinson, P. Lichtenstein, P. Lichtner, D. Liewald, LifeLines Cohort Study, Anu Loukola, P. Madden, R. Mägi, T. Mäki-Opas, R. Marioni, P. Marques-Vidal, Gerardus A. Meddens, George Mcmahon, Christa Meisinger, T. Meitinger, Y. Milaneschi, L. Milani, G. Montgomery, Ronny Myhre, Christopher P. Nelson, D. Nyholt, William E. R. Ollier, A. Palotie, L. Paternoster, Nancy L Pedersen, Katja E. Petrovic, D. Porteous, K. Räikkönen, Susan M. Ring, A. Robino, Olga Rostapshova, I. Rudan, Aldo Rustichini, V. Salomaa, A. Sanders, Antti-Pekka Sarin, H. Schmidt, Rodney J Scott, Blair H. Smith, Jennifer A Smith, J. Staessen, Elisabeth Steinhagen-Thiessen, K. Strauch, A. Terracciano, Martin D. Tobin, Sheila Ulivi, S. Vaccargiu, L. Quaye, F. V. van Rooij, Cristina Venturini, Anna A. E. Vinkhuyzen, U. Völker, H. Völzke, J. Vonk, D. Vozzi, Johannes Waage, E. Ware, G. Willemsen, J. Attia, David A. Bennett, Klaus Berger, L. Bertram, H. Bisgaard, D. Boomsma, I. Borecki, Ute Bültmann, C. Chabris, F. Cucca, D. Cusi, I. Deary, G. Dedoussis, Cornelia M. van Duijn, J. Eriksson, Barbara Franke, L. Franke, Paolo Gasparini, P. Gejman, C. Gieger, Hans‐Jörgen Grabe, J. Gratten, Patrick J. F. Groenen, V. Gudnason, P. van der Harst, Caroline Hayward, Wolfgang Hoffmann, Elina Hyppönen, W. Iacono, Bo Jacobsson, M. Järvelin, K. Jöckel, J. Kaprio, S. Kardia, T. Lehtimäki, Steven F. Lehrer, Patrik K. E. Magnusson, N. Martin, M. McGue, A. Metspalu, N. Pendleton, B. Penninx, M. Perola, N. Pirastu, Mario Pirastu, O. Polašek, D. Posthuma, Christine Power, M. A. Province, Nilesh J. Samani, D. Schlessinger, R. Schmidt, T. I. Sørensen, Timothy D Spector, K. Stefansson, U. Thorsteinsdóttir, A. Thurik, N. Timpson, Henning Tiemeier, J. Tung, A. Uitterlinden, V. Vitart, P. Vollenweider, David R. Weir, James F. Wilson, Alan F. Wright, D. Conley, Robert F. Krueger, G. D. Smith, A. Hofman, David Laibson, S. Medland, M. Meyer, Jian Yang, M. Johannesson, P. Visscher, T. Esko, P. Koellinger, D. Cesarini, Daniel J. Benjamin, Maris Alver, Y. Bao, D. Clark, F. Day, Peter K. Joshi, K. Kemper, A. Kleinman, C. Langenberg, J. Trampush, S. Verma, Yang Wu, M. Lam, J. Zhao, Zhili Zheng, J. Boardman, J. Freese, K. Harris, Caroline Hayward, P. Herd, M. Kumari, T. Lencz, J. Luan, A. Malhotra, L. Milani, K. Ong, J. Perry, M. Ritchie, M. Smart, Blair H. Smith, N. Wareham, James F. Wilson, J. Beauchamp, Patrik K. E. Magnusson, M. Robinson, Chelsea Watson, Jian Yang, M. Johannesson, P. Visscher, Daniel J. Benjamin +336 moresemanticscholar +1 more sourceGenomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma
Molecular Oncology, EarlyView.GA text
Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...Piotr J. Manasterski, Molly R. Danks, John P. Thomson, Morwenna Muir, Martin Lee, John C. Dawson, Ana T. Amaral, Juan Diaz‐Martin, David S. Moura, Javier Martin‐Broto, Ali Alsaadi, Donald M. Salter, Ailsa J. Oswald, Graeme Grimes, Larry Hayward, Ted R. Hupp, Karen Sisley, Paul H. Huang, Neil O. Carragher, Valerie G. Brunton +19 morewiley +1 more sourceUnraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma
Molecular Oncology, EarlyView.The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.Jenifer Brea‐Iglesias, Ana Oitabén, Sonia Zumalave, Bernardo Rodriguez‐Martin, María Gallardo‐Gómez, Martín Santamarina, Ana Pequeño‐Valtierra, Laura Juaneda‐Magdalena, Ramón García‐Escudero, José Luis López‐Cedrún, Máximo Fraga, José M. C. Tubio, Mónica Martínez‐Fernández +12 morewiley +1 more sourceIdentification of PVT1 as a Candidate Gene for End-Stage Renal Disease in Type 2 Diabetes Using a Pooling-Based Genome-Wide Single Nucleotide Polymorphism Association Study [PDF]
, 2007 Robert L. Hanson, David W. Craig, Meredith P. Millis, Kimberly Yeatts, Sayuko Kobes, John V. Pearson, Anne M. Lee, William C. Knowler, Robert G. Nelson, Johanna K. Wolford +9 moreopenalex +1 more sourceCytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models
Molecular Oncology, EarlyView.Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén +13 morewiley +1 more source
